ASIA-PACIFIC CRISPR MARKET 2021-2028

Lifesciences | Diagnostic & Biotechnology

ASIA-PACIFIC CRISPR MARKET 2021-2028

Market by Product, Application, Industry Verticals, and Country | Forecast 2021-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

As mentioned in Triton’s research report, the Asia-Pacific CRISPR market is projected to grow at 22.03% of CAGR during the forecasted period 2021-2028.


Report scope can be customized per your requirements. Request For Customization

The countries considered in this market include:

•        India

•        China

•        Japan

•        Australia & New Zealand

•        South Korea

•        ASEAN countries

•        Rest of Asia-Pacific

In Japan, the innovation in CRISPR technology is primarily driving the growth of the market. For instance, in March 2021, the first genome-edited tomato was launched by Sanatech Seed. As a result, the authorities have announced that the genome-edited tomato will not be regulated as a genetically modified product. Moreover, the tomato contains high levels of gamma-aminobutyric acid that aid in relaxation, lowering blood pressure. Furthermore, a new tool was identified at Tokushima University, known as type I-D (TiD), a lesser-known CRISPR system. However, its broader applications are being developed. Hence, the rising developments in CRISPR technology are likely to fuel the Japanese CRISPR market’s growth.

Likewise, New researches in CRISPR for agricultural sector will support the studied market’s growth in South Korea. For instance, in the recent past, G+FLAS Life Sciences Inc announced licensing two patents pertaining to non-GMO ways of plant genome engineering. Moreover, the licensed DNA-free CRISPR genome editing technologies permit the production of genome-edited crops without utilizing foreign DNA. Hence, these innovative steps are boosting the growth of the CRISPR market within South Korea.

OriGene Technologies Inc is a gene-centric life sciences company supporting academic, pharmaceutical, and biotech companies in researching gene functions and drug discovery. The company develops proteins, antibodies, and other molecular tools that enable researchers to analyze data on a multiplex level. Its product line includes CRISPRa SAM, a gene activation system that activates gene expression using CRISPR technology. OriGene has operations across various regions, including the Asia-Pacific. 

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. ASIA-PACIFIC CRISPR MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON CRISPR MARKET

2.2. KEY INSIGHTS

2.2.1. INDUSTRIAL BIOTECH IS THE FASTEST GROWING INDUSTRY VERTICAL

2.2.2. REWRITING OF GENETIC DISORDERS THROUGH GENOME SURGERY

2.2.3. INCREASING USAGE OF PROSPECTIVE APPLICATIONS OF CRISPR TECHNOLOGY

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTES

2.3.3. BARGAINING POWER OF BUYERS

2.3.4. BARGAINING POWER OF SUPPLIERS

2.3.5. THREAT OF COMPETITIVE RIVALRY

2.4. MARKET ATTRACTIVENESS INDEX

2.5. VENDOR SCORECARD

2.6. LEGAL & REGULATORY OUTLOOK

2.7. PATENT OUTLOOK

2.8. FUNDING OUTLOOK

2.9. KEY IMPACT ANALYSIS

2.9.1. COST

2.9.2. ACCURACY

2.9.3. EASY TO USE

2.10. KEY MARKET STRATEGIES

2.10.1. ACQUISITIONS

2.10.2. PRODUCT LAUNCHES

2.10.3. CONTRACTS & PARTNERSHIPS

2.10.4. BUSINESS EXPANSIONS & DIVESTITURES

2.11. MARKET DRIVERS

2.11.1. GROWING LIFESTYLE-ORIENTED DISEASES

2.11.2. SURGING PREVALENCE OF GENETIC DISEASES

2.12. MARKET CHALLENGES

2.12.1. GROWING ETHICAL ISSUES REGARDING TECHNOLOGY USE

2.12.2. LIKELY MISUSE OF GENE-EDITING TOOL

2.12.3. ABSENCE OF HEALTHCARE BUDGETS IN DEVELOPING COUNTRIES

2.13. MARKET OPPORTUNITIES

2.13.1. ADVANCEMENTS IN GENE-BASED THERAPY IN THE AGRICULTURAL SECTOR

2.13.2. INCREASED NEED FOR CLINICAL TRIALS

2.13.3. RISE IN AWARENESS ABOUT GENE THERAPEUTICS

3. ASIA-PACIFIC CRISPR MARKET OUTLOOK - BY PRODUCT

3.1. PLASMIDS

3.2. VECTORS

3.3. PROTEINS

3.4. DESIGNING TOOLS

3.5. GRNA

3.6. CONTROL KITS

3.7. LIBRARY

3.8. OTHER PRODUCTS

4. ASIA-PACIFIC CRISPR MARKET OUTLOOK - BY APPLICATION

4.1. GENOME EDITING/GENETIC ENGINEERING

4.2. CRISPR PLASMID

4.3. HUMAN STEM CELLS

4.4. GRNA DATABASE/GENE LIBRARY

4.5. CELL LINE ENGINEERING

5. ASIA-PACIFIC CRISPR MARKET OUTLOOK - BY INDUSTRY VERTICALS

5.1. THERAPEUTICS AND DRUG DISCOVERY

5.2. BIOLOGICAL RESEARCH

5.3. AGRICULTURAL BIOTECH

5.4. INDUSTRIAL BIOTECH

6. ASIA-PACIFIC CRISPR MARKET – REGIONAL OUTLOOK

6.1. CHINA

6.2. JAPAN

6.3. INDIA

6.4. SOUTH KOREA

6.5. ASEAN COUNTRIES

6.6. AUSTRALIA & NEW ZEALAND

6.7. REST OF ASIA PACIFIC

7. COMPETITIVE LANDSCAPE

7.1. ADDGENE

7.2. CARIBOU BIOSCIENCES INC

7.3. CELLECTIS BIORESEARCH SAS

7.4. CRISPR THERAPEUTICS AG

7.5. EDITAS MEDICINE

7.6. GENSCRIPT

7.7. HORIZON DISCOVERY GROUP

7.8. INTEGRATED DNA TECHNOLOGIES

7.9. INTELLIA THERAPEUTICS

7.10. LONZA GROUP LTD

7.11. NEW ENGLAND BIOLABS

7.12. NOVARTIS INTERNATIONAL AG

7.13. ORIGENE TECHNOLOGIES INC

7.14. PRECISION BIOSCIENCES

7.15. SYNTHEGO CORPORATION

8. RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.2. SOURCES OF DATA

8.3. RESEARCH METHODOLOGY

List of Tables

TABLE 1: ASIA-PACIFIC CRISPR MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)           

TABLE 2: VENDOR SCORECARD        

TABLE 3: REGULATORY FRAMEWORK         

TABLE 4: FUNDING OUTLOOK OF PUBLIC COMPANIES  

TABLE 5: FUNDING OUTLOOK OF PRIVATE COMPANIES

TABLE 6: FUNDING OUTLOOK OF GOVERNMENT ORGANIZATIONS   

TABLE 7: ASIA-PACIFIC CRISPR MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)           

TABLE 8: ASIA-PACIFIC CRISPR MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)    

TABLE 9: ASIA-PACIFIC CRISPR MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)      

TABLE 10: ASIA-PACIFIC CRISPR MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1: MARKET ATTRACTIVENESS INDEX       

FIGURE 2: FUNDING SCENARIO SHARE, BY TYPE OF COMPANIES/ORGANIZATION         

FIGURE 3: KEY IMPACT ANALYSIS     

FIGURE 4: ASIA-PACIFIC CRISPR MARKET, BY PRODUCT, 2020 & 2028 (IN %)        

FIGURE 5: ASIA-PACIFIC CRISPR MARKET, BY PLASMIDS, 2021-2028 (IN $ MILLION)        

FIGURE 6: ASIA-PACIFIC CRISPR MARKET, BY VECTORS, 2021-2028 (IN $ MILLION)         

FIGURE 7: ASIA-PACIFIC CRISPR MARKET, BY PROTEINS, 2021-2028 (IN $ MILLION)        

FIGURE 8: ASIA-PACIFIC CRISPR MARKET, BY DESIGNING TOOLS, 2021-2028 (IN $ MILLION)           

FIGURE 9: ASIA-PACIFIC CRISPR MARKET, BY GRNA, 2021-2028 (IN $ MILLION)     

FIGURE 10: ASIA-PACIFIC CRISPR MARKET, BY CONTROL KITS, 2021-2028 (IN $ MILLION)           

FIGURE 11: ASIA-PACIFIC CRISPR MARKET, BY LIBRARY, 2021-2028 (IN $ MILLION)         

FIGURE 12: ASIA-PACIFIC CRISPR MARKET, BY OTHER PRODUCTS, 2021-2028 (IN $ MILLION)      

FIGURE 13: ASIA-PACIFIC CRISPR MARKET, BY APPLICATION, 2020 & 2028 (IN %)

FIGURE 14: ASIA-PACIFIC CRISPR MARKET, BY GENOME EDITING/GENETIC ENGINEERING, 2021-2028 (IN $ MILLION)

FIGURE 15: ASIA-PACIFIC CRISPR MARKET, BY CRISPR PLASMID, 2021-2028 (IN $ MILLION)           

FIGURE 16: ASIA-PACIFIC CRISPR MARKET, BY HUMAN STEM CELLS, 2021-2028 (IN $ MILLION)      

FIGURE 17: ASIA-PACIFIC CRISPR MARKET, BY GRNA DATABASE/GENE LIBRARY, 2021-2028 (IN $ MILLION)          

FIGURE 18: ASIA-PACIFIC CRISPR MARKET, BY CELL LINE ENGINEERING, 2021-2028 (IN $ MILLION)      

FIGURE 19: ASIA-PACIFIC CRISPR MARKET, BY INDUSTRY VERTICALS, 2020 & 2028 (IN %)           

FIGURE 20: ASIA-PACIFIC CRISPR MARKET, BY THERAPEUTICS AND DRUG DISCOVERY, 2021-2028 (IN $ MILLION)

FIGURE 21: ASIA-PACIFIC CRISPR MARKET, BY BIOLOGICAL RESEARCH, 2021-2028 (IN $ MILLION)      

FIGURE 22: ASIA-PACIFIC CRISPR MARKET, BY AGRICULTURAL BIOTECH, 2021-2028 (IN $ MILLION)      

FIGURE 23: ASIA-PACIFIC CRISPR MARKET, BY INDUSTRIAL BIOTECH, 2021-2028 (IN $ MILLION)      

FIGURE 24: ASIA-PACIFIC CRISPR MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)   

FIGURE 25: CHINA CRISPR MARKET 2021-2028 (IN $ MILLION)  

FIGURE 26: JAPAN CRISPR MARKET 2021-2028 (IN $ MILLION) 

FIGURE 27: INDIA CRISPR MARKET 2021-2028 (IN $ MILLION)   

FIGURE 28: SOUTH KOREA CRISPR MARKET 2021-2028 (IN $ MILLION)         

FIGURE 29: ASEAN COUNTRIES CRISPR MARKET 2021-2028 (IN $ MILLION)

FIGURE 30: AUSTRALIA & NEW ZEALAND CRISPR MARKET 2021-2028 (IN $ MILLION)      

FIGURE 31: REST OF ASIA-PACIFIC CRISPR MARKET 2021-2028 (IN $ MILLION)      

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;